The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil

Clinical trial NCT01680510 · UNKNOWN

Trial details

NCT number: NCT01680510
Sponsor: Sheba Medical Center
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Retinitis Pigmentosa

Start date: 2012-09-01
Primary completion: 2025-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.